《2008美國先天性心臟病指南》內(nèi)容簡介：

    It is important that the medical profession play a central rolein critically evaluating the use of diagnostic procedures andtherapies introduced and tested for detection, management, orprevention of disease. Rigorous, expert **ysis of the avail-able data documenting absolute and relative benefits and risksof these procedures and therapies can produce guidelines thatimprove the effectiveness of care, optimize patient outcomes,and favorably affect the cost of care by focusing resources onthe most effective strategies.

    《2008美國先天性心臟病指南》內(nèi)容預(yù)覽：

    The American College of Cardiology Foundation （ACCF）and the American Heart Association （AHA） have jointlyengaged in the production of guidelines in the area ofcardiovascular disease since 1980. The American College ofCardiology （ACC）/AHA Task Force on Practice Guidelinesis charged with developing, updating, and revising practiceguidelines for cardiovascular diseases and procedures anddirects this effort. Writing committees are charged withassessing the evidence as an independent group of authors todevelop, update, or revise recommendations for clinicalpractice.

    Experts in the subject under consideration have beenselected from both organizations to examine subject-specificdata and write guidelines in partnership with representativesfrom other medical practitioner and specialty groups. Writingcommittees are specifically charged to perform a formalliterature review, weigh the strength of evidence for oragainst particular treatments or procedures, and includeestimates of expected health outcomes where data exist.Patient-specific modifiers, comorbidities, and issues of pa-tient preference that might influence the choice of tests ortherapies are considered, as well as the frequency offollow-up and cost-effectiveness. When available, ***rma-tion from studies on cost is considered, but data on efficacyand clinical outcomes constitute the primary basis for recom-mendations in these guidelines.

    點(diǎn)擊下載***：《2008美國先天性心臟病指南》